Page last updated: 2024-12-04

3-mercaptopyruvic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-mercaptopyruvic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-mercaptopyruvic acid : A 2-oxo monocarboxylic acid that is pyruvic acid substituted by a sulfanyl group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID98
CHEBI ID16208
SCHEMBL ID188201
MeSH IDM0052133

Synonyms (37)

Synonym
brn 1747058
2-oxo-3-sulfanylpropanoic acid
CHEBI:16208
3-mercapto-2-oxopropanoic acid
beta-thiopyruvic acid
beta-mercaptopyruvic acid
propanoic acid, 3-mercapto-2-oxo- (9ci)
pyruvic acid, mercapto- (6ci,7ci,8ci)
pyruvic acid, 3-mercapto-
mercaptopyruvic acid
propanoic acid, 3-mercapto-2-oxo-
3-MERCAPTO-PYRUVATE ,
mercaptopyruvate
3-mercaptopyruvic acid
beta-thiopyruvate
C00957
beta-mercaptopyruvate
2464-23-5
AKOS006223734
unii-5z1f5ow4yb
5z1f5ow4yb ,
4-03-00-01936 (beilstein handbook reference)
gtpl5118
SCHEMBL188201
pyruvic acid, mercapto-
.beta.-thiopyruvic acid
3-mercapto-2-oxopropionic acid
FT-0696976
beta-3-mercapto-2-oxo-propanoate
thiopyruvate
3-mercapto-pyruvic acid
beta-3-mercapto-2-oxo-propanoic acid
Q4634163
2-oxo-3-sulfanylpropanoicacid
DTXSID20862960
EN300-1166901
PD051014

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Urinary excretion of thiocyanate by hens after dosage with cyanide was studied over 3 hr periods during which various sulphur sources were infused."( Alternative sulphur donors for detoxification of cyanide in the chicken.
Davis, RH; Mousa, HM, 1991
)
0.28
" The dose of 100 micrograms per 100 g of body wt administered for a shorter period, and the use of a lower dosage (50 micrograms T4 per 100 g of body wt) for 6 days had a stimulatory effect upon MPST activity level, and an increased level of sulfane sulfur was observed."( Effects of thyroxine on L-cysteine desulfuration in mouse liver.
Abe, T; Ubuka, T; Wróbel, M; Yao, WB, 2000
)
0.31
" The current suite of FDA approved antidotes, including hydroxocobalamin, sodium nitrite, and sodium thiosulfate is effective, but each antidote has specific major limitations, such as large effective dosage or delayed onset of action."( Determination of 3-mercaptopyruvate in rabbit plasma by high performance liquid chromatography tandem mass spectrometry.
Logue, BA; Mitchell, BL; Monteil, AR; Patterson, SE; Stutelberg, MW; Vinnakota, CV, 2014
)
0.4
", large effective dosage or delayed onset of action)."( Simultaneous determination of 3-mercaptopyruvate and cobinamide in plasma by liquid chromatography-tandem mass spectrometry.
Boss, GR; Dzisam, JK; Logue, BA; Monteil, AR; Patterson, SE; Petrikovics, I; Rockwood, GA; Stutelberg, MW, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
antidote to cyanide poisoningA role borne by a molecule that acts to counteract or neutralize the deleterious effects of cyanide.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
2-oxo monocarboxylic acidAny monocarboxylic acid having a 2-oxo substituent.
thiolAn organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (15)

PathwayProteinsCompounds
Metabolism14961108
Amino acid and derivative metabolism250260
Sulfur amino acid metabolism2763
Degradation of cysteine and homocysteine1538
Cysteine Metabolism923
beta-Mercaptolactate-Cysteine Disulfiduria923
Cystinosis, Ocular Nonnephropathic923
Hydrogen Sulfide Biosynthesis I511
2-Oxo-glutaric acid + L-Cysteine = L-Glutamic acid + 3-Mercapto-pyruvic acid ( Glycine and Serine metabolism )24
Methionine and Cysteine metabolism ( Methionine and Cysteine metabolism )2342
2-Oxo-glutaric acid + L-Cysteine = L-Glutamic acid + 3-Mercapto-pyruvic acid ( Methionine and Cysteine metabolism )24
NAD+ + 3-Mercapto-lactic acid = NADH + 3-Mercapto-pyruvic acid ( Methionine and Cysteine metabolism )44
Biochemical pathways: part I0466
Amino acid metabolism094
Cysteine degradation619

Research

Studies (65)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (35.38)18.7374
1990's8 (12.31)18.2507
2000's8 (12.31)29.6817
2010's23 (35.38)24.3611
2020's3 (4.62)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.78 (24.57)
Research Supply Index4.22 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (5.97%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other63 (94.03%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]